Keith Lamont Cummings
Chief Financial Officer · PLIANT THERAPEUTICS, INC.
- 2026
- Apr 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Keith Lamont Cummings files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bernard Coulie - $114K in PLRX purchases and sales in the last 12 months
- Lily Cheung - $10K in PLRX purchases and sales in the last 12 months
- Minnie Kuo - $9K in PLRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Keith Lamont Cummings?
Keith Lamont Cummings is a corporate insider, tracked as Chief Financial Officer of PLIANT THERAPEUTICS, INC. (PLRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Keith Lamont Cummings last file a Form 4?
The most recent primary Form 4 on record is dated 17 April 2026, one of 3 filings going back to 2026.
Has Keith Lamont Cummings been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($31K) across all tracked filings.
